← All Sponsors
SPONSOR

Instituto Sexológico Murciano

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Pelvic Pain

Instituto Sexológico Murciano is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Pelvic Pain.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Instituto Sexológico Murciano

How many clinical trials has Instituto Sexológico Murciano sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Instituto Sexológico Murciano, of which 1 are actively recruiting participants. These trials cover conditions including Pelvic Pain. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Instituto Sexológico Murciano research focus on?
Instituto Sexológico Murciano clinical trials span Pelvic Pain. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Instituto Sexológico Murciano clinical trial?
To participate in a Instituto Sexológico Murciano trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Instituto Sexológico Murciano trials with current recruitment status updated daily.

Clinical Trials by Instituto Sexológico Murciano

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology